HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q1 2022. The put-call ratio across all filers is 4.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | -19.8% | 25,429 | -3.3% | 0.00% | – |
| Q4 2021 | $96,000 | -51.0% | 26,303 | +5.0% | 0.00% | – |
| Q3 2021 | $196,000 | +21.7% | 25,053 | +12.3% | 0.00% | – |
| Q2 2021 | $161,000 | +15.8% | 22,307 | +51.3% | 0.00% | – |
| Q1 2021 | $139,000 | -50.5% | 14,742 | -40.8% | 0.00% | – |
| Q4 2020 | $281,000 | +83.7% | 24,896 | +72.9% | 0.00% | – |
| Q3 2020 | $153,000 | -79.7% | 14,396 | -70.9% | 0.00% | -100.0% |
| Q2 2020 | $752,000 | +375.9% | 49,534 | +387.2% | 0.00% | – |
| Q1 2020 | $158,000 | -27.9% | 10,168 | -3.9% | 0.00% | – |
| Q4 2019 | $219,000 | -92.1% | 10,577 | -93.1% | 0.00% | -100.0% |
| Q3 2019 | $2,776,000 | +686.4% | 153,394 | +749.2% | 0.00% | – |
| Q2 2019 | $353,000 | -45.5% | 18,063 | -22.7% | 0.00% | -100.0% |
| Q1 2019 | $648,000 | +81.0% | 23,370 | +45.8% | 0.00% | – |
| Q4 2018 | $358,000 | – | 16,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
| Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
| AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
| Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
| Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
| PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
| American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
| Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
| FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |